M-m-r II vaccine vials

Ended Awarded Last action

Contract number
SPE2DR26F02GX
Awardee
Awarding agency
Obligated
$20,693

Award facts

Contract value 100% obligated
$20,693.41 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $20,693.41 delivery order to Amerisourcebergen Drug Corp on May 11, 2026, for M-M-R II vaccine vials, with an ultimate completion date of May 12, 2026.

Amerisourcebergen Drug Corp is a pharmaceutical distributor subsidiary of Cencora, Inc., operating under a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for military healthcare supply. Place of performance is Conshohocken, PA. The order carries firm fixed-price pricing with no set-aside applied.

Quick answers

Who was awarded contract SPE2DR26F02GX?

SPE2DR26F02GX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 11, 2026.

How much is contract SPE2DR26F02GX worth?

The government has obligated $20,693 on SPE2DR26F02GX.

Is contract SPE2DR26F02GX an order under another contract?

Yes. SPE2DR26F02GX is a delivery order under SPE2DR25D3505, an indefinite delivery contract.

Was contract SPE2DR26F02GX competed?

The extent of competition for SPE2DR26F02GX was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award